Aging-dependent Mitochondrial Dysfunction Mediated by Ceramide Signaling Inhibits Antitumor T Cell Response

Silvia Vaena,Paramita Chakraborty,Han Gyul Lee,Alhaji H. Janneh,Mohamed Faisal Kassir,Gyda Beeson,Zachariah Hedley,Ahmet Yalcinkaya,M. Hanief Sofi,Hong Li,Monica L. Husby,Robert Stahelin,Xue-Zhong Yu,Shikhar Mehrotra,Besim Ogretmen
DOI: https://doi.org/10.1016/j.celrep.2021.109076
IF: 8.8
2021-01-01
Cell Reports
Abstract:We lack a mechanistic understanding of aging-mediated changes in mitochondrial bioenergetics and lipid metabolism that affect T cell function. The bioactive sphingolipid ceramide, induced by aging stress, mediates mitophagy and cell death; however, the aging-related roles of ceramide metabolism in regulating T cell function remain unknown. Here, we show that activated T cells isolated from aging mice have elevated C14/C16 ceramide accumulation in mitochondria, generated by ceramide synthase 6, leading to mitophagy/mitochondrial dysfunction. Mechanistically, aging-dependent mitochondrial ceramide inhibits protein kinase A, leading to mitophagy in activated T cells. This aging/ceramide-dependent mitophagy attenuates the antitumor functions of T cells in vitro and in vivo. Also, inhibition of ceramide metabolism or PKA activation by genetic and pharmacologic means prevents mitophagy and restores the central memory phenotype in aging T cells. Thus, these studies help explain the mechanisms behind aging-related dysregulation of T cells' antitumor activity, which can be restored by inhibiting ceramide-dependent mitophagy.
What problem does this paper attempt to address?